Clinical Trials Browser

Completed × Infections × Rituximab × Clear all

NCT06790420 2025-05-31

RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study

Infections, Lymphoma